JNJ Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2024-03-13 | 2023 | P. Fasolo EVP, Chief Human Resources Officer | 877,692 | 0 | 2,999,620 | 1,160,000 | 110,744 | 7,502,047 |
| 2024-03-13 | 2023 | A. McEvoy Former EVP, WWC MedTech | 1,059,231 | 0 | 4,015,750 | 1,261,500 | 47,665 | 9,403,150 |
| 2024-03-13 | 2022 | A. McEvoy Former EVP, WWC MedTech | 984,615 | 0 | 3,935,021 | 890,250 | 44,308 | 7,390,161 |
| 2024-03-13 | 2022 | J. Wolk EVP, CFO | 1,008,462 | 0 | 4,718,897 | 1,177,800 | 75,971 | 8,823,082 |
| 2024-03-13 | 2023 | J. Wolk EVP, CFO | 1,147,962 | 0 | 5,766,005 | 1,928,800 | 98,072 | 13,914,853 |
| 2024-03-13 | 2021 | J. Duato Chairman/CEO | 1,030,000 | 0 | 7,001,281 | 2,319,450 | 184,796 | 13,805,292 |
| 2024-03-13 | 2022 | J. Duato Chairman/CEO | 1,490,962 | 0 | 5,940,829 | 3,079,750 | 268,987 | 13,099,487 |
| 2024-03-13 | 2023 | J. Duato Chairman/CEO | 1,584,615 | 0 | 11,182,143 | 4,378,500 | 241,992 | 28,397,240 |
| 2024-03-13 | 2021 | J. Wolk EVP, CFO | 938,077 | 0 | 4,877,538 | 1,560,863 | 78,243 | 10,953,615 |
| 2024-03-13 | 2023 | J. Reed EVP, Innovative Medicine, R&D | 840,385 | 5,700,000 | 11,699,934 | 1,720,000 | 313,031 | 20,647,350 |
| 2024-03-13 | 2023 | J. Taubert EVP, WWC Innovative Medicine | 1,130,000 | 0 | 4,246,820 | 1,896,250 | 78,332 | 10,995,394 |
| 2024-03-13 | 2022 | J. Taubert EVP, WWC Innovative Medicine | 1,008,462 | 0 | 4,764,921 | 1,094,875 | 53,316 | 8,781,532 |
| 2024-03-13 | 2021 | J. Taubert EVP, WWC Innovative Medicine | 938,077 | 0 | 4,947,245 | 1,510,314 | 49,707 | 10,225,759 |
| 2023-03-15 | 2020 | J. Wolk EVP, CFO | 885,385 | 0 | 4,163,841 | 1,044,179 | 46,636 | 10,196,038 |
| 2023-03-15 | 2021 | J. Duato Chairman/CEO | 1,030,000 | 0 | 7,001,281 | 2,319,450 | 184,796 | 13,805,292 |
| 2023-03-15 | 2020 | J. Duato Chairman/CEO | 1,021,538 | 0 | 6,798,093 | 1,820,403 | 45,969 | 15,625,003 |
| 2023-03-15 | 2022 | J. Wolk EVP, CFO | 1,008,462 | 0 | 4,718,897 | 1,177,800 | 75,971 | 8,823,082 |
| 2023-03-15 | 2022 | T. Mongon EVP, Worldwide Chair Consumer Health | 917,308 | 0 | 3,681,233 | 798,000 | 196,900 | 7,092,410 |
| 2023-03-15 | 2022 | A. McEvoy EVP, Worldwide Chair MedTech | 984,615 | 0 | 3,935,021 | 890,250 | 44,308 | 7,390,161 |
| 2023-03-15 | 2020 | J. Taubert EVP, Worldwide Chair Pharmaceuticals | 884,615 | 0 | 4,468,928 | 990,058 | 46,871 | 9,532,469 |
| 2023-03-15 | 2021 | J. Taubert EVP, Worldwide Chair Pharmaceuticals | 938,077 | 0 | 4,947,245 | 1,510,314 | 49,707 | 10,225,759 |
| 2023-03-15 | 2022 | J. Taubert EVP, Worldwide Chair Pharmaceuticals | 1,008,462 | 0 | 4,764,921 | 1,094,875 | 53,316 | 8,781,532 |
| 2023-03-15 | 2022 | J. Duato Chairman/CEO | 1,490,962 | 0 | 5,940,829 | 3,079,750 | 268,987 | 13,099,487 |
| 2023-03-15 | 2021 | J. Wolk EVP, CFO | 938,077 | 0 | 4,877,538 | 1,560,863 | 78,243 | 10,953,615 |
| 2022-03-16 | 2019 | Jennifer Taubert EVP, Worldwide Chair Pharmaceuticals | 796,154 | 0 | 2,625,279 | 1,179,065 | 59,798 | 7,097,300 |
| 2022-03-16 | 2021 | Alex Gorsky Chairman/CEO | 1,650,000 | 0 | 14,789,176 | 4,252,800 | 277,071 | 26,741,959 |
| 2022-03-16 | 2021 | Joseph Wolk EVP, CFO | 938,077 | 0 | 4,877,538 | 1,560,863 | 78,243 | 10,953,615 |
| 2022-03-16 | 2019 | Alex Gorsky Chairman/CEO | 1,650,000 | 0 | 9,956,365 | 3,690,971 | 243,444 | 25,365,777 |
| 2022-03-16 | 2020 | Alex Gorsky Chairman/CEO | 1,650,000 | 0 | 13,757,654 | 3,148,515 | 200,810 | 29,575,974 |
| 2022-03-16 | 2021 | Paulus Stoffels VC of the Executive Committee, CSO | 1,222,500 | 0 | 7,487,478 | 2,660,400 | 102,189 | 15,007,450 |
| 2022-03-16 | 2020 | Paulus Stoffels VC of the Executive Committee, CSO | 1,222,500 | 0 | 6,871,123 | 2,056,395 | 82,949 | 16,439,968 |
| 2022-03-16 | 2019 | Paulus Stoffels VC of the Executive Committee, CSO | 1,222,500 | 0 | 4,824,472 | 2,388,631 | 73,238 | 14,067,849 |
| 2022-03-16 | 2021 | Joaquin Duato Vice Chairman of the Executive Committee | 1,030,000 | 0 | 7,001,281 | 2,319,450 | 184,796 | 13,805,292 |
| 2022-03-16 | 2020 | Joaquin Duato Vice Chairman of the Executive Committee | 1,021,538 | 0 | 6,798,093 | 1,820,403 | 45,969 | 15,625,003 |
| 2022-03-16 | 2019 | Joaquin Duato Vice Chairman of the Executive Committee | 969,615 | 0 | 4,622,787 | 2,295,437 | 88,458 | 13,419,302 |
| 2022-03-16 | 2021 | Jennifer Taubert EVP, Worldwide Chair Pharmaceuticals | 938,077 | 0 | 4,947,245 | 1,510,314 | 49,707 | 10,225,759 |
| 2022-03-16 | 2020 | Jennifer Taubert EVP, Worldwide Chair Pharmaceuticals | 884,615 | 0 | 4,468,928 | 990,058 | 46,871 | 9,532,469 |
| 2022-03-16 | 2019 | Joseph Wolk EVP, CFO | 796,538 | 0 | 2,379,419 | 1,132,914 | 81,818 | 7,497,692 |
| 2022-03-16 | 2020 | Joseph Wolk EVP, CFO | 885,385 | 0 | 4,163,841 | 1,044,179 | 46,636 | 10,196,038 |
| 2021-03-10 | 2019 | Joseph Wolk EVP, CFO | 796,538 | 0 | 2,379,419 | 1,132,914 | 81,818 | 7,497,692 |
| 2021-03-10 | 2020 | Jennifer Taubert EVP, Worldwide Chair Pharmaceuticals | 884,615 | 0 | 4,468,928 | 990,058 | 46,871 | 9,532,469 |
| 2021-03-10 | 2018 | Joaquin Duato Vice Chairman of the Executive Committee | 934,046 | 0 | 4,275,951 | 2,010,088 | 91,876 | 9,283,960 |
| 2021-03-10 | 2019 | Joaquin Duato Vice Chairman of the Executive Committee | 969,615 | 0 | 4,622,787 | 2,295,437 | 88,458 | 13,419,302 |
| 2021-03-10 | 2020 | Joaquin Duato Vice Chairman of the Executive Committee | 1,021,538 | 0 | 6,798,093 | 1,820,403 | 45,969 | 15,625,003 |
| 2021-03-10 | 2018 | Paulus Stoffels VC of the Executive Committee, CSO | 1,178,300 | 0 | 4,666,961 | 2,191,603 | 390,897 | 10,591,765 |
| 2021-03-10 | 2019 | Paulus Stoffels VC of the Executive Committee, CSO | 1,222,500 | 0 | 4,824,472 | 2,388,631 | 73,238 | 14,067,849 |
| 2021-03-10 | 2020 | Paulus Stoffels VC of the Executive Committee, CSO | 1,222,500 | 0 | 6,871,123 | 2,056,395 | 82,949 | 16,439,968 |
| 2021-03-10 | 2018 | Joseph Wolk EVP, CFO | 597,542 | 0 | 670,085 | 749,729 | 32,935 | 2,708,189 |
| 2021-03-10 | 2019 | Jennifer Taubert EVP, Worldwide Chair Pharmaceuticals | 796,154 | 0 | 2,625,279 | 1,179,065 | 59,798 | 7,097,300 |
| 2021-03-10 | 2020 | Joseph Wolk EVP, CFO | 885,385 | 0 | 4,163,841 | 1,044,179 | 46,636 | 10,196,038 |
| 2021-03-10 | 2018 | Alex Gorsky Chairman/CEO | 1,642,308 | 0 | 10,319,463 | 3,570,497 | 259,710 | 20,097,572 |
| 2021-03-10 | 2019 | Alex Gorsky Chairman/CEO | 1,650,000 | 0 | 9,956,365 | 3,690,971 | 243,444 | 25,365,777 |
| 2021-03-10 | 2020 | Alex Gorsky Chairman/CEO | 1,650,000 | 0 | 13,757,654 | 3,148,515 | 200,810 | 29,575,974 |
| 2020-03-11 | 2019 | Alex Gorsky Chairman/CEO | 1,650,000 | 0 | 9,956,365 | 3,690,971 | 243,444 | 25,365,777 |
| 2020-03-11 | 2018 | Alex Gorsky Chairman/CEO | 1,642,308 | 0 | 10,319,463 | 3,570,497 | 259,710 | 20,097,572 |
| 2020-03-11 | 2019 | Joseph Wolk EVP, CFO | 796,538 | 0 | 2,379,419 | 1,132,914 | 81,818 | 7,497,692 |
| 2020-03-11 | 2018 | Joseph Wolk EVP, CFO | 597,542 | 0 | 670,085 | 749,729 | 32,935 | 2,708,189 |
| 2020-03-11 | 2019 | Paulus Stoffels VC of the Executive Committee, CSO | 1,222,500 | 0 | 4,824,472 | 2,388,631 | 73,238 | 14,067,849 |
| 2020-03-11 | 2018 | Paulus Stoffels VC of the Executive Committee, CSO | 1,178,300 | 0 | 4,666,961 | 2,191,603 | 390,897 | 10,591,765 |
| 2020-03-11 | 2017 | Paulus Stoffels VC of the Executive Committee, CSO | 1,173,023 | 0 | 4,630,306 | 2,139,188 | 443,139 | 13,580,786 |
| 2020-03-11 | 2019 | Joaquin Duato Vice Chairman of the Executive Committee | 969,615 | 0 | 4,622,787 | 2,295,437 | 88,458 | 13,419,302 |
| 2020-03-11 | 2018 | Joaquin Duato Vice Chairman of the Executive Committee | 934,046 | 0 | 4,275,951 | 2,010,088 | 91,876 | 9,283,960 |
| 2020-03-11 | 2017 | Joaquin Duato Vice Chairman of the Executive Committee | 897,254 | 0 | 11,483,016 | 1,928,262 | 71,726 | 19,359,308 |
| 2020-03-11 | 2019 | Jennifer Taubert | 796,154 | 0 | 2,625,279 | 1,179,065 | 59,798 | 7,097,300 |
| 2019-03-13 | 2018 | Alex Gorsky Chairman/CEO | 1,642,308 | 0 | 10,319,463 | 3,570,497 | 259,710 | 20,097,572 |
| 2019-03-13 | 2017 | Alex Gorsky Chairman/CEO | 1,600,000 | 0 | 12,354,361 | 3,598,382 | 236,279 | 29,802,564 |
| 2019-03-13 | 2018 | Joseph Wolk | 597,542 | 0 | 670,085 | 749,729 | 32,935 | 2,708,189 |
| 2019-03-13 | 2018 | Paulus Stoffels VC of the Executive Committee, CSO | 1,178,300 | 0 | 4,666,961 | 2,191,603 | 390,897 | 10,591,765 |
| 2019-03-13 | 2017 | Paulus Stoffels VC of the Executive Committee, CSO | 1,173,023 | 0 | 4,630,306 | 2,139,188 | 443,139 | 13,580,786 |
| 2019-03-13 | 2016 | Paulus Stoffels VC of the Executive Committee, CSO | 1,144,000 | 0 | 4,383,454 | 2,425,461 | 380,232 | 12,725,476 |
| 2019-03-13 | 2018 | Joaquin Duato Vice Chairman of the Executive Committee | 934,046 | 0 | 4,275,951 | 2,010,088 | 91,876 | 9,283,960 |
| 2019-03-13 | 2017 | Joaquin Duato Vice Chairman of the Executive Committee | 897,254 | 0 | 11,483,016 | 1,928,262 | 71,726 | 19,359,308 |
| 2019-03-13 | 2016 | Joaquin Duato Vice Chairman of the Executive Committee | 875,000 | 0 | 3,198,483 | 2,158,006 | 77,278 | 10,104,529 |
| 2019-03-13 | 2018 | Michael Ullmann | 788,077 | 0 | 1,968,687 | 1,276,665 | 44,730 | 5,336,152 |
| 2019-03-13 | 2018 | Dominic Caruso Former EVP, CFO | 630,538 | 0 | 3,677,454 | 727,531 | 131,322 | 6,711,846 |
| 2019-03-13 | 2017 | Dominic Caruso Former EVP, CFO | 932,600 | 0 | 4,263,779 | 2,156,680 | 159,172 | 11,736,202 |
| 2019-03-13 | 2018 | Sandra Peterson Former EVP, Group Worldwide Chairman | 808,500 | 0 | 4,002,361 | 1,005,500 | 2,901,505 | 10,679,873 |
| 2019-03-13 | 2017 | Sandra Peterson Former EVP, Group Worldwide Chairman | 1,057,500 | 0 | 12,027,780 | 1,270,000 | 128,780 | 17,176,056 |
| 2019-03-13 | 2016 | Sandra Peterson Former EVP, Group Worldwide Chairman | 963,462 | 0 | 3,897,074 | 1,600,000 | 141,246 | 8,732,784 |
| 2018-03-14 | 2016 | Dominic Caruso EVP, CFO | 0 | 0 | 0 | 0 | 0 | 0 |
| 2018-03-14 | 2017 | Alex Gorsky Chairman, CEO | 1,600,000 | 0 | 12,354,361 | 3,598,382 | 236,279 | 29,802,564 |
| 2018-03-14 | 2016 | Alex Gorsky Chairman, CEO | 0 | 0 | 0 | 0 | 0 | 0 |
| 2018-03-14 | 2015 | Alex Gorsky Chairman, CEO | 0 | 0 | 0 | 0 | 0 | 0 |
| 2018-03-14 | 2017 | Dominic Caruso EVP, CFO | 0 | 0 | 0 | 0 | 0 | 0 |
| 2018-03-14 | 2015 | Dominic Caruso EVP, CFO | 0 | 0 | 0 | 0 | 0 | 0 |
| 2018-03-14 | 2017 | Sandra Peterson EVP, Group Worldwide Chairman | 0 | 0 | 0 | 0 | 0 | 0 |
| 2018-03-14 | 2016 | Sandra Peterson EVP, Group Worldwide Chairman | 0 | 0 | 0 | 0 | 0 | 0 |
| 2018-03-14 | 2015 | Sandra Peterson EVP, Group Worldwide Chairman | 0 | 0 | 0 | 0 | 0 | 0 |
| 2018-03-14 | 2017 | Joaquin Duato EVP, Worldwide Chairman Pharmaceuticals | 0 | 0 | 0 | 0 | 0 | 0 |
| 2018-03-14 | 2016 | Joaquin Duato EVP, Worldwide Chairman Pharmaceuticals | 0 | 0 | 0 | 0 | 0 | 0 |
| 2018-03-14 | 2017 | Paulus Stoffels EVP, CSO | 0 | 0 | 0 | 0 | 0 | 0 |
| 2018-03-14 | 2016 | Paulus Stoffels EVP, CSO | 0 | 0 | 0 | 0 | 0 | 0 |
| 2018-03-14 | 2015 | Paulus Stoffels EVP, CSO | 0 | 0 | 0 | 0 | 0 | 0 |
| 2017-03-15 | 2015 | Dominic Caruso EVP, CFO | 0 | 0 | 0 | 0 | 0 | 0 |
| 2017-03-15 | 2016 | Dominic Caruso EVP, CFO | 0 | 0 | 0 | 0 | 0 | 0 |
| 2017-03-15 | 2014 | Alex Gorsky Chairman, CEO | 0 | 0 | 0 | 0 | 0 | 0 |
| 2017-03-15 | 2016 | Alex Gorsky Chairman, CEO | 1,600,000 | 0 | 10,608,901 | 4,652,556 | 228,094 | 26,871,720 |
| 2017-03-15 | 2015 | Alex Gorsky Chairman, CEO | 0 | 0 | 0 | 0 | 0 | 0 |
| 2017-03-15 | 2016 | Joaquin Duato | 0 | 0 | 0 | 0 | 0 | 0 |
| 2017-03-15 | 2014 | Sandra Peterson EVP, Group Worldwide Chairman | 0 | 0 | 0 | 0 | 0 | 0 |
| 2017-03-15 | 2015 | Sandra Peterson EVP, Group Worldwide Chairman | 0 | 0 | 0 | 0 | 0 | 0 |
| 2017-03-15 | 2016 | Sandra Peterson EVP, Group Worldwide Chairman | 0 | 0 | 0 | 0 | 0 | 0 |
| 2017-03-15 | 2014 | Paulus Stoffels EVP, CSO | 0 | 0 | 0 | 0 | 0 | 0 |
| 2017-03-15 | 2015 | Paulus Stoffels EVP, CSO | 0 | 0 | 0 | 0 | 0 | 0 |
| 2017-03-15 | 2016 | Paulus Stoffels EVP, CSO | 0 | 0 | 0 | 0 | 0 | 0 |
| 2017-03-15 | 2014 | Dominic Caruso EVP, CFO | 0 | 0 | 0 | 0 | 0 | 0 |
| 2016-03-16 | 2013 | Sandra Peterson Group Worldwide Chairman | 800,000 | 1,900,000 | 635,867 | 1,200,000 | 527,396 | 5,637,261 |
| 2016-03-16 | 2013 | Dominic Caruso VP, Finance, CFO | 842,308 | 0 | 2,663,229 | 3,222,868 | 112,911 | 8,233,315 |
| 2016-03-16 | 2014 | Dominic Caruso VP, Finance, CFO | 878,115 | 0 | 3,271,853 | 3,234,152 | 121,299 | 10,349,033 |
| 2016-03-16 | 2015 | Dominic Caruso VP, Finance, CFO | 922,577 | 0 | 3,497,099 | 2,772,796 | 112,789 | 9,689,400 |
| 2016-03-16 | 2013 | Alex Gorsky Chairman/CEO | 1,453,846 | 0 | 5,988,975 | 4,867,361 | 191,779 | 16,910,960 |
| 2016-03-16 | 2014 | Alex Gorsky Chairman/CEO | 1,500,000 | 0 | 9,467,380 | 5,018,779 | 228,866 | 24,989,306 |
| 2016-03-16 | 2013 | Michael Ullmann VP, General Counsel | 542,308 | 0 | 1,390,982 | 1,348,953 | 30,845 | 4,363,336 |
| 2016-03-16 | 2014 | Michael Ullmann VP, General Counsel | 591,346 | 0 | 1,615,191 | 1,502,105 | 36,171 | 5,960,691 |
| 2016-03-16 | 2015 | Michael Ullmann VP, General Counsel | 645,385 | 0 | 1,962,425 | 1,162,936 | 35,125 | 5,676,353 |
| 2016-03-16 | 2015 | Alex Gorsky Chairman/CEO | 1,613,462 | 0 | 10,693,427 | 4,009,536 | 202,175 | 23,795,866 |
| 2016-03-16 | 2014 | Sandra Peterson Group Worldwide Chairman | 841,346 | 0 | 2,833,545 | 1,400,000 | 192,714 | 7,086,606 |
| 2016-03-16 | 2015 | Sandra Peterson Group Worldwide Chairman | 908,654 | 0 | 3,504,177 | 1,125,000 | 147,000 | 7,626,452 |
| 2016-03-16 | 2013 | Paulus Stoffels Chief Scientific Officer; Worldwide Chairman, Pharmaceuticals | 952,923 | 0 | 2,580,468 | 2,416,809 | 404,802 | 7,822,001 |
| 2016-03-16 | 2014 | Paulus Stoffels Chief Scientific Officer; Worldwide Chairman, Pharmaceuticals | 1,075,423 | 0 | 10,690,520 | 2,573,450 | 425,088 | 18,339,317 |
| 2016-03-16 | 2015 | Paulus Stoffels Chief Scientific Officer; Worldwide Chairman, Pharmaceuticals | 1,158,385 | 0 | 4,208,874 | 2,172,098 | 401,118 | 10,785,745 |
| 2015-03-11 | 2014 | Sandra Peterson Group Worldwide Chairman | 841,346 | 0 | 2,833,545 | 1,400,000 | 192,714 | 7,086,606 |
| 2015-03-11 | 2014 | Paulus Stoffels | 1,075,423 | 0 | 10,690,520 | 2,573,450 | 425,088 | 18,339,317 |
| 2015-03-11 | 2014 | Dominic Caruso | 878,115 | 0 | 3,271,853 | 3,234,152 | 121,299 | 10,349,033 |
| 2015-03-11 | 2012 | Sandra Peterson Group Worldwide Chairman | 46,154 | 300,000 | 4,300,017 | 0 | 52,679 | 4,698,850 |
| 2015-03-11 | 2013 | Sandra Peterson Group Worldwide Chairman | 800,000 | 1,900,000 | 635,867 | 1,200,000 | 527,396 | 5,637,261 |
| 2015-03-11 | 2013 | Alex Gorsky Chairman/CEO | 1,453,846 | 0 | 5,988,975 | 4,867,361 | 191,779 | 16,910,960 |
| 2015-03-11 | 2014 | Alex Gorsky Chairman/CEO | 1,500,000 | 0 | 9,467,380 | 5,018,779 | 228,866 | 24,989,306 |
| 2015-03-11 | 2014 | Michael Ullmann VP, General Counsel | 591,346 | 0 | 1,615,191 | 1,502,105 | 36,171 | 5,960,691 |
| 2015-03-11 | 2013 | Michael Ullmann VP, General Counsel | 542,308 | 0 | 1,390,982 | 1,348,953 | 30,845 | 4,363,336 |
| 2014-03-12 | 2013 | Dominic Caruso VP, Finance, CFO | 842,308 | 0 | 2,663,229 | 3,222,868 | 112,911 | 8,233,315 |
| 2014-03-12 | 2012 | Paulus Stoffels Chief Scientific Officer; Worldwide Chair, Pharmaceuticals | 825,385 | 0 | 1,926,252 | 2,305,251 | 161,466 | 7,336,924 |
| 2014-03-12 | 2013 | Sandra Peterson Group Worldwide Chair | 800,000 | 1,900,000 | 635,867 | 1,200,000 | 527,396 | 5,637,261 |
| 2014-03-12 | 2013 | Michael Ullmann | 542,308 | 0 | 1,390,982 | 1,348,953 | 30,845 | 4,363,336 |
| 2014-03-12 | 2012 | Sandra Peterson Group Worldwide Chair | 46,154 | 300,000 | 4,300,017 | 0 | 52,679 | 4,698,850 |
| 2014-03-12 | 2013 | Paulus Stoffels Chief Scientific Officer; Worldwide Chair, Pharmaceuticals | 952,923 | 0 | 2,580,468 | 2,416,809 | 404,802 | 7,822,001 |
| 2014-03-12 | 2011 | Dominic Caruso VP, Finance, CFO | 773,023 | 0 | 676,740 | 2,971,065 | 49,694 | 6,442,302 |
| 2014-03-12 | 2012 | Dominic Caruso VP, Finance, CFO | 796,385 | 0 | 2,089,563 | 3,014,577 | 84,009 | 8,009,837 |
| 2014-03-12 | 2011 | Alex Gorsky Chairman/CEO | 847,692 | 0 | 673,222 | 2,836,003 | 82,782 | 6,836,860 |
| 2014-03-12 | 2012 | Alex Gorsky Chairman/CEO | 1,087,188 | 0 | 2,790,229 | 3,407,287 | 159,774 | 10,977,109 |
| 2014-03-12 | 2013 | Alex Gorsky Chairman/CEO | 1,453,846 | 0 | 5,988,975 | 4,867,361 | 191,779 | 16,910,960 |
| 2013-03-13 | 2012 | Sandra Peterson | 46,154 | 300,000 | 4,300,017 | 0 | 52,679 | 4,698,850 |
| 2013-03-13 | 2011 | Alex Gorsky Chairman/CEO | 847,692 | 0 | 673,222 | 2,836,003 | 82,782 | 6,836,860 |
| 2013-03-13 | 2012 | Peter Fasolo | 534,769 | 0 | 1,387,098 | 715,209 | 33,163 | 3,621,281 |
| 2013-03-13 | 2012 | William Weldon Former Chairman/CEO | 1,320,578 | 0 | 7,565,328 | 13,447,666 | 234,688 | 29,838,259 |
| 2013-03-13 | 2011 | William Weldon Former Chairman/CEO | 1,907,215 | 0 | 2,608,694 | 14,336,394 | 321,153 | 26,797,939 |
| 2013-03-13 | 2010 | William Weldon Former Chairman/CEO | 1,851,154 | 0 | 2,773,851 | 12,043,200 | 254,436 | 28,720,491 |
| 2013-03-13 | 2012 | Dominic Caruso VP, Finance; CFO | 796,385 | 0 | 2,089,563 | 3,014,577 | 84,009 | 8,009,837 |
| 2013-03-13 | 2011 | Dominic Caruso VP, Finance; CFO | 773,023 | 0 | 676,740 | 2,971,065 | 49,694 | 6,442,302 |
| 2013-03-13 | 2010 | Dominic Caruso VP, Finance; CFO | 749,854 | 0 | 566,102 | 2,550,400 | 71,819 | 5,632,285 |
| 2013-03-13 | 2012 | Alex Gorsky Chairman/CEO | 1,087,188 | 0 | 2,790,229 | 3,407,287 | 159,774 | 10,977,109 |
| 2013-03-13 | 2012 | Paulus Stoffels | 825,385 | 0 | 1,926,252 | 2,305,251 | 161,466 | 7,336,924 |
| 2012-03-14 | 2011 | Dominic J. Caruso VP, Finance; CFO | 773,023 | 0 | 676,740 | 2,971,065 | 49,694 | 6,442,302 |
| 2012-03-14 | 2009 | William C. Weldon Chairman/CEO | 1,802,500 | 0 | 2,762,532 | 12,831,146 | 196,587 | 30,813,844 |
| 2012-03-14 | 2010 | William C. Weldon Chairman/CEO | 1,851,154 | 0 | 2,773,851 | 12,043,200 | 254,436 | 28,720,491 |
| 2012-03-14 | 2011 | William C. Weldon Chairman/CEO | 1,907,215 | 0 | 2,608,694 | 14,336,394 | 321,153 | 26,797,939 |
| 2012-03-14 | 2010 | Dominic J. Caruso VP, Finance; CFO | 749,854 | 0 | 566,102 | 2,550,400 | 71,819 | 5,632,285 |
| 2012-03-14 | 2009 | Sherilyn S. McCoy Vice Chairman, Executive Committee | 747,731 | 0 | 407,599 | 2,626,630 | 36,890 | 5,780,034 |
| 2012-03-14 | 2010 | Sherilyn S. McCoy Vice Chairman, Executive Committee | 780,377 | 0 | 679,311 | 3,221,760 | 78,443 | 7,517,104 |
| 2012-03-14 | 2011 | Sherilyn S. McCoy Vice Chairman, Executive Committee | 897,806 | 0 | 705,437 | 3,924,807 | 64,716 | 8,733,678 |
| 2012-03-14 | 2011 | Alex Gorsky | 847,692 | 0 | 673,222 | 2,836,003 | 82,782 | 6,836,860 |
| 2012-03-14 | 2009 | Russell C. Deyo VP, General Counsel | 831,838 | 0 | 611,372 | 3,608,760 | 45,535 | 8,631,394 |
| 2012-03-14 | 2010 | Russell C. Deyo VP, General Counsel | 867,377 | 0 | 622,707 | 3,831,820 | 112,688 | 8,851,965 |
| 2012-03-14 | 2011 | Russell C. Deyo VP, General Counsel | 895,269 | 0 | 783,714 | 3,967,694 | 70,744 | 8,975,035 |
| 2012-03-14 | 2009 | Dominic J. Caruso VP, Finance; CFO | 723,739 | 0 | 486,847 | 2,441,300 | 43,708 | 5,220,350 |
| 2011-03-16 | 2009 | William C. Weldon Chairman/CEO | 1,802,500 | 0 | 2,762,532 | 12,831,146 | 196,587 | 30,813,844 |
| 2011-03-16 | 2008 | Dominic J. Caruso VP, Finance; CFO | 701,442 | 0 | 389,612 | 1,999,500 | 43,995 | 4,219,180 |
| 2011-03-16 | 2010 | Russell C. Deyo VP, General Counsel | 867,377 | 0 | 622,707 | 3,831,820 | 112,688 | 8,851,965 |
| 2011-03-16 | 2009 | Russell C. Deyo VP, General Counsel | 831,838 | 0 | 611,372 | 3,608,760 | 45,535 | 8,631,394 |
| 2011-03-16 | 2008 | Russell C. Deyo VP, General Counsel | 804,096 | 0 | 618,749 | 3,513,100 | 123,700 | 7,981,511 |
| 2011-03-16 | 2010 | Sherilyn S. McCoy Vice Chairman, Executive Committee | 780,377 | 0 | 679,311 | 3,221,760 | 78,443 | 7,517,104 |
| 2011-03-16 | 2010 | Colleen A. Goggins WW Chairman, Consumer Group | 823,031 | 0 | 634,107 | 3,404,650 | 62,378 | 7,738,614 |
| 2011-03-16 | 2009 | Colleen A. Goggins WW Chairman, Consumer Group | 795,854 | 0 | 634,037 | 3,784,070 | 60,453 | 8,316,896 |
| 2011-03-16 | 2008 | Colleen A. Goggins WW Chairman, Consumer Group | 766,635 | 0 | 630,240 | 3,687,885 | 69,844 | 7,778,185 |
| 2011-03-16 | 2009 | Sherilyn S. McCoy Vice Chairman, Executive Committee | 747,731 | 0 | 407,599 | 2,626,630 | 36,890 | 5,780,034 |
| 2011-03-16 | 2010 | William C. Weldon Chairman/CEO | 1,851,154 | 0 | 2,773,851 | 12,043,200 | 254,436 | 28,720,491 |
| 2011-03-16 | 2009 | Dominic J. Caruso VP, Finance; CFO | 723,739 | 0 | 486,847 | 2,441,300 | 43,708 | 5,220,350 |
| 2011-03-16 | 2010 | Dominic J. Caruso VP, Finance; CFO | 749,854 | 0 | 566,102 | 2,550,400 | 71,819 | 5,632,285 |
| 2011-03-16 | 2008 | William C. Weldon Chairman/CEO | 1,792,019 | 0 | 2,452,129 | 12,598,260 | 303,688 | 29,127,432 |
| 2010-03-17 | 2007 | Colleen A. Goggins WW Chairman, Consumer Group | 729,923 | 0 | 579,872 | 3,884,500 | 72,269 | 7,858,395 |
| 2010-03-17 | 2009 | Sherilyn S. McCoy WW Chairman, Pharmaceuticals Group | 747,731 | 0 | 407,599 | 2,626,630 | 36,890 | 5,780,034 |
| 2010-03-17 | 2008 | Colleen A. Goggins WW Chairman, Consumer Group | 766,635 | 0 | 630,240 | 3,687,885 | 69,844 | 7,778,185 |
| 2010-03-17 | 2009 | Colleen A. Goggins WW Chairman, Consumer Group | 795,854 | 0 | 634,037 | 3,784,070 | 60,453 | 8,316,896 |
| 2010-03-17 | 2007 | Russell C. Deyo VP, HR & General Counsel | 769,616 | 0 | 579,872 | 3,945,000 | 92,560 | 8,378,547 |
| 2010-03-17 | 2008 | Russell C. Deyo VP, HR & General Counsel | 804,096 | 0 | 618,749 | 3,513,100 | 123,700 | 7,981,511 |
| 2010-03-17 | 2009 | Russell C. Deyo VP, HR & General Counsel | 831,838 | 0 | 611,372 | 3,608,760 | 45,535 | 8,631,394 |
| 2010-03-17 | 2007 | Dominic J. Caruso VP, Finance, CFO | 550,000 | 0 | 208,754 | 1,550,100 | 53,648 | 3,141,350 |
| 2010-03-17 | 2008 | Dominic J. Caruso VP, Finance, CFO | 701,442 | 0 | 389,612 | 1,999,500 | 43,995 | 4,219,180 |
| 2010-03-17 | 2009 | Dominic J. Caruso VP, Finance, CFO | 723,739 | 0 | 486,847 | 2,441,300 | 43,708 | 5,220,350 |
| 2010-03-17 | 2007 | William C. Weldon Chairman/CEO | 1,725,000 | 0 | 2,319,368 | 12,136,520 | 271,757 | 28,404,762 |
| 2010-03-17 | 2008 | William C. Weldon Chairman/CEO | 1,792,019 | 0 | 2,452,129 | 12,598,260 | 303,688 | 29,127,432 |
| 2010-03-17 | 2009 | William C. Weldon Chairman/CEO | 1,802,500 | 0 | 2,762,532 | 12,831,146 | 196,587 | 30,813,844 |
| 2009-03-11 | 2008 | Dominic J. Caruso VP, Finance, CFO | 701,442 | 0 | 275,992 | 1,640,500 | 402,995 | 3,921,028 |
| 2009-03-11 | 2006 | William C. Weldon Chairman/CEO | 1,659,231 | 0 | 2,041,054 | 7,461,440 | 2,665,725 | 29,576,934 |
| 2009-03-11 | 2007 | William C. Weldon Chairman/CEO | 1,725,000 | 0 | 2,319,368 | 9,188,120 | 3,220,157 | 30,641,458 |
| 2009-03-11 | 2008 | William C. Weldon Chairman/CEO | 1,792,019 | 0 | 2,452,129 | 8,972,360 | 3,929,588 | 29,392,224 |
| 2009-03-11 | 2007 | Colleen A. Goggins WW Chairman, Consumer Group | 729,923 | 0 | 365,332 | 2,920,600 | 1,036,169 | 7,934,261 |
| 2009-03-11 | 2008 | Colleen A. Goggins WW Chairman, Consumer Group | 766,635 | 0 | 741,682 | 2,619,860 | 1,137,869 | 8,490,272 |
| 2009-03-11 | 2006 | Russell C. Deyo VP, General Counsel | 735,385 | 0 | 510,236 | 2,207,176 | 1,144,259 | 8,907,373 |
| 2009-03-11 | 2007 | Russell C. Deyo VP, General Counsel | 769,616 | 0 | 579,872 | 2,746,200 | 1,291,360 | 9,064,441 |
| 2009-03-11 | 2008 | Russell C. Deyo VP, General Counsel | 804,096 | 0 | 618,749 | 2,184,800 | 1,452,000 | 8,062,240 |
| 2009-03-11 | 2006 | Christine A. Poon* Vice Chairman WW Chairman, Pharmaceuticals Group | 967,308 | 0 | 270,596 | 2,389,600 | 1,021,083 | 8,170,380 |
| 2009-03-11 | 2007 | Christine A. Poon* Vice Chairman WW Chairman, Pharmaceuticals Group | 1,008,846 | 0 | 613,667 | 3,718,000 | 1,198,421 | 10,143,847 |
| 2009-03-11 | 2008 | Christine A. Poon* Vice Chairman WW Chairman, Pharmaceuticals Group | 1,042,404 | 0 | 912,366 | 3,721,500 | 1,293,151 | 10,402,493 |
| 2009-03-11 | 2007 | Dominic J. Caruso VP, Finance, CFO | 550,000 | 0 | 153,657 | 1,266,600 | 337,148 | 2,995,623 |
| 2008-03-12 | 2007 | Dominic J. Caruso VP, Finance, CFO | 550,000 | 0 | 153,657 | 1,266,600 | 337,148 | 3,078,372 |
| 2008-03-12 | 2007 | William C. Weldon Chairman/CEO | 1,725,000 | 0 | 2,319,368 | 9,188,120 | 3,220,157 | 31,916,566 |
| 2008-03-12 | 2007 | Colleen A. Goggins WW Chairman, Consumer Group | 729,923 | 0 | 365,332 | 2,920,600 | 1,036,169 | 8,379,759 |
| 2008-03-12 | 2007 | Russell C. Deyo VP, General Counsel | 769,616 | 0 | 579,872 | 2,746,200 | 1,291,360 | 9,672,168 |
| 2008-03-12 | 2006 | Russell C. Deyo VP, General Counsel | 735,385 | 0 | 510,236 | 2,207,176 | 1,144,259 | 8,387,691 |
| 2008-03-12 | 2007 | Christine A. Poon Vice Chairman | 1,008,846 | 0 | 613,667 | 3,718,000 | 1,198,421 | 10,543,161 |
| 2008-03-12 | 2006 | Christine A. Poon Vice Chairman | 967,308 | 0 | 270,596 | 2,389,600 | 1,021,083 | 7,881,464 |
| 2008-03-12 | 2006 | William C. Weldon Chairman/CEO | 1,659,231 | 0 | 2,041,054 | 7,461,440 | 2,665,725 | 28,557,749 |
| 2007-03-14 | 2006 | Russell C. Deyo VP, General Counsel/Chief Compliance Officer | 735,385 | 0 | 510,236 | 2,207,176 | 1,144,259 | 8,387,691 |
| 2007-03-14 | 2006 | Christine A. Poon Vice Chairman | 967,308 | 0 | 270,596 | 2,389,600 | 1,021,083 | 7,881,464 |
| 2007-03-14 | 2006 | Robert J. Darretta Vice Chairman/CFO | 1,023,846 | 0 | 626,226 | 2,574,880 | 1,577,864 | 11,263,525 |
| 2007-03-14 | 2006 | William C. Weldon Chairman/CEO | 1,659,231 | 0 | 2,041,054 | 7,461,440 | 2,665,725 | 28,557,749 |
| 2007-03-14 | 2006 | Per A. Peterson Chairman, R&D Pharmaceuticals Group | 830,692 | 0 | 579,841 | 2,312,400 | 883,392 | 8,700,118 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
